Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career ...

Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

MATFORCE and the Yavapai County Sheriff’s Office held their annual Youth Poster Contest again this year to help raise ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of ...

At the core of the new releases is Kuiper, Biognosys' novel search engine, powered by proprietary prediction models specifically optimized for unspecific searches. Kuiper delivers record-breaking ...

The pharmaceutical industry faces big challenges in drug discovery today – rising costs, high failure rates, and increasingly complex target diseases.

Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with traditional biology research to accelerate drug discovery, today announced ...

One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is ...

Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug discovery and proteomics, announced today the appointment of two new members to its ...